{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T13:23:09Z","timestamp":1694611389503},"reference-count":40,"publisher":"The Editorial Office of Gut and Liver","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut Liver"],"published-print":{"date-parts":[[2015,11,23]]},"DOI":"10.5009\/gnl14297","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T21:28:31Z","timestamp":1431379711000},"page":"776","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B"],"prefix":"10.5009","volume":"9","author":[{"given":"Sangheun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, International St. Mary\u2019s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kijun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jin","family":"Ku","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hyub","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Brain Korea 21 Project for Medical Science, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Brain Korea 21 Project for Medical Science, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2920","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw, YF","year":"2009","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz, JF","year":"2006","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2010.06545.x","article-title":"Treatment of chronic hepatitis B: evolution over two decades","volume":"26","author":"Yuen, MF","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-147-11-200712040-00183","article-title":"Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial","volume":"147","author":"Chan, HL","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"Liaw, YF","year":"2009","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis, SJ","year":"2006","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002030-200501030-00012","article-title":"Antiretroviral therapy with tenofovir is associated with mild renal dysfunction","volume":"19","author":"Mauss, S","year":"2005","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2013.09.031","article-title":"Telbivudine improves renal function in patients with chronic hepatitis B","volume":"146","author":"Gane, EJ","year":"2014","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey, AS","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref10","first-page":"17","article-title":"Treatment of hypertension: guidelines from JNC 7 (the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1)","volume":"55","author":"Cuddy, ML","year":"2005","journal-title":"J Pract Nurs"},{"issue":"Suppl 1","key":"ref11","first-page":"S11","article-title":"Standards of medical care in diabetes: 2011","volume":"34","author":",","year":"2011","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2893.2010.01412.x","article-title":"Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine","volume":"18","author":"Zou, XJ","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2009.04.019","article-title":"Clevudine myopathy in patients with chronic hepatitis B","volume":"51","author":"Kim, BK","year":"2009","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.23044","article-title":"Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil","volume":"50","author":"Ha, NB","year":"2009","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23346","article-title":"Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function","volume":"50","author":"Lange, CM","year":"2009","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3748\/wjg.v11.i12.1843","article-title":"Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection","volume":"11","author":"Schiefke, I","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1523-1755.2004.00866.x","article-title":"Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies","volume":"66","author":"Izzedine, H","year":"2004","journal-title":"Kidney Int"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cgh.2012.04.008","article-title":"Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B","volume":"10","author":"Gish, RG","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje, UH","year":"2006","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B","volume":"354","author":"Chang, TT","year":"2006","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.5009\/gnl.2013.7.6.712","article-title":"Continuous long-term entecavir therapy in naive chronic hepatitis B patients showing partial virologic response","volume":"7","author":"Kwon, DH","year":"2013","journal-title":"Gut Liver"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/liv.12377","article-title":"Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir","volume":"34","author":"Kim, MN","year":"2014","journal-title":"Liver Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31829a7247","article-title":"Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir","volume":"48","author":"Kim, MN","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.23327","article-title":"Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B","volume":"51","author":"Chang, TT","year":"2010","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2007.08.025","article-title":"Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B","volume":"133","author":"Gish, RG","year":"2007","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai, CL","year":"2007","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2008.12.019","article-title":"Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B","volume":"51","author":"Zeuzem, S","year":"2009","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.3748\/wjg.v19.i43.7671","article-title":"Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir","volume":"19","author":"Park, H","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12072-011-9314-7","article-title":"Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B","volume":"6","author":"Ahn, SH","year":"2012","journal-title":"Hepatol Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2893.2012.01600.x","article-title":"Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naive patients with HBV-related decompensated cirrhosis","volume":"19","author":"Chan, HL","year":"2012","journal-title":"J Viral Hepat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jac\/dkr495","article-title":"A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice","volume":"67","author":"Tsai, MC","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/hr.2013.22","article-title":"Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria","volume":"36","author":"Nishimura, M","year":"2013","journal-title":"Hypertens Res"},{"issue":"Suppl 1","key":"ref33","first-page":"S14","article-title":"Standards of medical care in diabetes: 2014","volume":"37","author":",","year":"2014","journal-title":"Diabetes Care"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/j.ajkd.2007.12.016","article-title":"CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999\u20132004","volume":"51","author":"Whaley-Connell, AT","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0272-6386(96)90380-7","article-title":"Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group","volume":"28","author":"Buckalew, VM","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00134-005-2842-7","article-title":"The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis","volume":"31","author":"du Cheyron, D","year":"2005","journal-title":"Intensive Care Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao, G","year":"2008","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico, G","year":"2006","journal-title":"J Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10620-010-1390-3","article-title":"Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS","volume":"56","author":"Al Sibae, MR","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e15074","DOI":"10.5812\/hepatmon.15074","article-title":"Decrease of serum angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates","volume":"14","author":"Liang, KH","year":"2014","journal-title":"Hepat Mon"}],"container-title":["Gut and Liver"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/ekjg\/ekjg009-06-16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T07:24:25Z","timestamp":1498202665000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.gutnliver.org\/journal\/view.html?doi=10.5009\/gnl14297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11,23]]}},"alternative-id":["10.5009\/gnl14297"],"URL":"https:\/\/doi.org\/10.5009\/gnl14297","relation":{},"ISSN":["1976-2283","2005-1212"],"issn-type":[{"value":"1976-2283","type":"print"},{"value":"2005-1212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,23]]}}}